Real-time · AI · Cross-signal
Cellular Origins just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Cellular Origins, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Cellular Origins and Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Oct 16, 2024•over 1 year ago
Contract Type
agreement
Description
Cellular Origins and Fresenius Kabi have signed a development agreement to integrate Fresenius Kabi’s suite of cell therapy processing technologies within Cellular Origins’ CGT robotic manufacturing platform Constellation™. The aim of this work is to assist cell therapy developers to manufacture their therapies at scale using their preferred processing tools.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months